Hepatitis B Virus News and Research

RSS

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

July 28th is marked as world hepatitis day. The world is united in elimination of viral hepatitis by 2030. The World Health Organization (WHO) has published new data from 28 countries today and shown that nearly 70% of the world hepatitis burden is borne by these countries.

27 Jul 2017

Scientists notice shift in transmission mechanism of HEV infections

Hepatitis E gets little press compared to its better-known cousins A, B, and C, but Stellenbosch University virologists say we should wake up to how transmission of this virus is changing. World Hepatitis Day is commemorated on 28 July.

27 Jul 2017

Princeton scientists test cell-culture system to aid study of HBV infections

Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections

25 Jul 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

Cancer death rates in rural America slower to decline compared to urban areas

According to the CDC, the cancer death rates nationwide have been on the decline. The reduction in these rates however is much slower in the rural areas than in other regions.

6 Jul 2017

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Many individuals with the blood disorder thalassaemia also carry the hepatitis C virus (HCV) due to contaminated transfusions before 1990.

29 Jun 2017

UNC researchers identify how class of antiviral drugs interacts with HCV

Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today.

9 Jun 2017

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

The survey results suggest a wide variation in existing national testing policy and practice when it comes to hepatitis B and C - with overall limited monitoring of testing, diagnosis, and treatment across EU/EEA Member States.

1 Jun 2017

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

18 May 2017

Study finds substantial increase in hepatitis C infections among pregnant women

Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.

11 May 2017

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

8 May 2017

Study uncovers potential new therapeutic targets for HCV infections

An international study led by researchers at Monash University' Biomedicine Discovery Institute (BDI) has shone light on the way the Hepatitis C Virus (HCV) hijacks the communication systems in the host cells it infects, uncovering potential new therapeutic targets for the disease.

8 May 2017

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Genotyping of patients with advanced cirrhosis from hepatitis C virus could help health-care professionals predict the likelihood of improvement after successful hepatitis C treatment, thus minimizing the need for liver transplants.

8 May 2017

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

24 Apr 2017

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

The World Health Organization (WHO) has published the first-ever Global Hepatitis Report. The World Hepatitis Alliance (WHA) welcomes the publication, which is a follow-up to WHO’s Global Strategy on Viral Hepatitis, and has set the goal to eliminate viral hepatitis as a public health threat by 2030.

21 Apr 2017

Periodic check-ups are essential to maintain health and longevity of baby boomers

For some baby boomers, getting ready for a routine visit with their doctor is like training for a marathon. Some patients want to be in the best shape possible before stepping on that scale and getting those lab results.

19 Apr 2017

Injection drug use linked to increase in immune activation, says researcher

The use of heroin and other illicit drugs has been shown to trigger a response from the body's immune system.

13 Apr 2017

FDA grants approval for two drugs to treat hepatitis C virus in children

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

7 Apr 2017

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The hepatitis virus affects the liver.

29 Mar 2017

Statin drugs may offer treatment option for chronic liver disease

Statin drugs are widely used to manage high cholesterol and reduce the risk of cardiovascular disease. But in a new review of more than 50 studies, researchers cite reductions in liver inflammation and improvements in other related factors as reasons why statins make good candidates for treating chronic liver disease.

23 Mar 2017

Hepatitis B Virus News and Research

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

Scientists notice shift in transmission mechanism of HEV infections

Princeton scientists test cell-culture system to aid study of HBV infections

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Cancer death rates in rural America slower to decline compared to urban areas

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

UNC researchers identify how class of antiviral drugs interacts with HCV

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Study finds substantial increase in hepatitis C infections among pregnant women

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Study uncovers potential new therapeutic targets for HCV infections

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

Periodic check-ups are essential to maintain health and longevity of baby boomers

Injection drug use linked to increase in immune activation, says researcher

FDA grants approval for two drugs to treat hepatitis C virus in children

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

Statin drugs may offer treatment option for chronic liver disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News